Session III: ADC/iADC: Iza-bren: BMS's First Bispecific ADC, and Pumitamig, the PD-L1×VEGF-A Bispecific Antibody (SITC 2026) - Sep 29, 2026 - Pres time: Nov 5, 2026; 01:45 PM - 01:55 PM; Location: Sheraton - 2nd Level – Valley of the Sun Ballroom; No abstract available
ADC • Bispecific • Oncology
|